Studies on the regulation of protein expression and molecular mechanisms of polyunsaturated fatty acids in human aortic endothelial cells and hepatic cells

博士 === 國立陽明大學 === 生化暨分子生物研究所 === 103 === Dietary polyunsaturated fatty acids (PUFAs) alleviate the progression of cardiovascular disease, but the underlying mechanisms within vascular cells remain unclear. The aim of this study was to investigate the biological function and regulatory mechanisms of...

Full description

Bibliographic Details
Main Authors: Chun-Ying Huang, 黃淳瑩
Other Authors: An-Na Chiang
Format: Others
Language:zh-TW
Published: 2015
Online Access:http://ndltd.ncl.edu.tw/handle/95233496474653220580
id ndltd-TW-103YM005107013
record_format oai_dc
spelling ndltd-TW-103YM0051070132016-08-17T04:23:22Z http://ndltd.ncl.edu.tw/handle/95233496474653220580 Studies on the regulation of protein expression and molecular mechanisms of polyunsaturated fatty acids in human aortic endothelial cells and hepatic cells 多元不飽和脂肪酸在人類主動脈內皮細胞與肝臟細胞中調控蛋白質表現與分子機轉之研究 Chun-Ying Huang 黃淳瑩 博士 國立陽明大學 生化暨分子生物研究所 103 Dietary polyunsaturated fatty acids (PUFAs) alleviate the progression of cardiovascular disease, but the underlying mechanisms within vascular cells remain unclear. The aim of this study was to investigate the biological function and regulatory mechanisms of PUFAs in the human aortic endothelial cells (HAECs), HepG2 cells and the liver of apolipoprotein E (apo E)-knockout mice. In the studies of vascular cells, our results showed that n-3 PUFAs docosahexaenoic acid (DHA) and eicosapentaenoic acid (EPA) remarkably attenuated lipopolysaccharide (LPS)-induced the adhesion of THP-1 monocytes to HAECs, probably through inhibiting the expression of vascular cell adhesion molecule 1 (VCAM-1) and intercellular adhesion molecule 1 (ICAM-1). Using lipid raft isolation and confocal microscopy, we found that DHA and EPA suppressed the translocation of toll-like receptor 4 (TLR4) into lipid rafts in HAECs. Furthermore, DHA and EPA inhibited the ubiquitination and translocation of TNF receptor-associated factor-6 (TRAF6), and the phosphorylation of transforming growth factor-beta (TGF beta)-activated kinase 1 (TAK1), p38, and IkappaBalpha. We demonstrated that DHA reduced the phosphorylation of PKR, but EPA increased the expression of A20 in HAECs. Additionally, silencing of A20 reversed the inhibitory effect of EPA on the expression of adhesion molecules. The liver is the essential metabolic center, which aids in maintaining health via diverse biological actions. The present study also used different PUFAs including DHA, EPA, arachidonic acid (AA), or linoleic acid (LA) to fed apoE-knockout mice for ten weeks. Plasma levels of triacylglycerol were significantly decreased in the DHA-fed and EPA-fed mice compared to those of the control mice. In contrast, plasma total cholesterol levels were significantly higher in the LA-fed group, while plasma levels of HDL-cholesterol and LDL-cholesterol were not statistically different among the five groups. Additionally, we investigated how n-3 PUFAs modulate the inflammatory response induced by interleukin (IL)-1β and IL-6 in HepG2 cells. The results showed that n-3 PUFAs inhibited the activation of nuclear factor-kappaB (NF-kappaB), the phosphorylation of nuclear signal transducer and activator of transcription 3 (STAT3) and the production of C-reactive protein (CRP) in HepG2 cells. Taken together, n-3 PUFAs exert their anti-inflammatory properties through differential molecular mechanisms in HAECs and HepG2 cells, suggesting promising strategies for the prevention of inflammatory diseases such as atherosclerosis. An-Na Chiang 姜安娜 2015 學位論文 ; thesis 113 zh-TW
collection NDLTD
language zh-TW
format Others
sources NDLTD
description 博士 === 國立陽明大學 === 生化暨分子生物研究所 === 103 === Dietary polyunsaturated fatty acids (PUFAs) alleviate the progression of cardiovascular disease, but the underlying mechanisms within vascular cells remain unclear. The aim of this study was to investigate the biological function and regulatory mechanisms of PUFAs in the human aortic endothelial cells (HAECs), HepG2 cells and the liver of apolipoprotein E (apo E)-knockout mice. In the studies of vascular cells, our results showed that n-3 PUFAs docosahexaenoic acid (DHA) and eicosapentaenoic acid (EPA) remarkably attenuated lipopolysaccharide (LPS)-induced the adhesion of THP-1 monocytes to HAECs, probably through inhibiting the expression of vascular cell adhesion molecule 1 (VCAM-1) and intercellular adhesion molecule 1 (ICAM-1). Using lipid raft isolation and confocal microscopy, we found that DHA and EPA suppressed the translocation of toll-like receptor 4 (TLR4) into lipid rafts in HAECs. Furthermore, DHA and EPA inhibited the ubiquitination and translocation of TNF receptor-associated factor-6 (TRAF6), and the phosphorylation of transforming growth factor-beta (TGF beta)-activated kinase 1 (TAK1), p38, and IkappaBalpha. We demonstrated that DHA reduced the phosphorylation of PKR, but EPA increased the expression of A20 in HAECs. Additionally, silencing of A20 reversed the inhibitory effect of EPA on the expression of adhesion molecules. The liver is the essential metabolic center, which aids in maintaining health via diverse biological actions. The present study also used different PUFAs including DHA, EPA, arachidonic acid (AA), or linoleic acid (LA) to fed apoE-knockout mice for ten weeks. Plasma levels of triacylglycerol were significantly decreased in the DHA-fed and EPA-fed mice compared to those of the control mice. In contrast, plasma total cholesterol levels were significantly higher in the LA-fed group, while plasma levels of HDL-cholesterol and LDL-cholesterol were not statistically different among the five groups. Additionally, we investigated how n-3 PUFAs modulate the inflammatory response induced by interleukin (IL)-1β and IL-6 in HepG2 cells. The results showed that n-3 PUFAs inhibited the activation of nuclear factor-kappaB (NF-kappaB), the phosphorylation of nuclear signal transducer and activator of transcription 3 (STAT3) and the production of C-reactive protein (CRP) in HepG2 cells. Taken together, n-3 PUFAs exert their anti-inflammatory properties through differential molecular mechanisms in HAECs and HepG2 cells, suggesting promising strategies for the prevention of inflammatory diseases such as atherosclerosis.
author2 An-Na Chiang
author_facet An-Na Chiang
Chun-Ying Huang
黃淳瑩
author Chun-Ying Huang
黃淳瑩
spellingShingle Chun-Ying Huang
黃淳瑩
Studies on the regulation of protein expression and molecular mechanisms of polyunsaturated fatty acids in human aortic endothelial cells and hepatic cells
author_sort Chun-Ying Huang
title Studies on the regulation of protein expression and molecular mechanisms of polyunsaturated fatty acids in human aortic endothelial cells and hepatic cells
title_short Studies on the regulation of protein expression and molecular mechanisms of polyunsaturated fatty acids in human aortic endothelial cells and hepatic cells
title_full Studies on the regulation of protein expression and molecular mechanisms of polyunsaturated fatty acids in human aortic endothelial cells and hepatic cells
title_fullStr Studies on the regulation of protein expression and molecular mechanisms of polyunsaturated fatty acids in human aortic endothelial cells and hepatic cells
title_full_unstemmed Studies on the regulation of protein expression and molecular mechanisms of polyunsaturated fatty acids in human aortic endothelial cells and hepatic cells
title_sort studies on the regulation of protein expression and molecular mechanisms of polyunsaturated fatty acids in human aortic endothelial cells and hepatic cells
publishDate 2015
url http://ndltd.ncl.edu.tw/handle/95233496474653220580
work_keys_str_mv AT chunyinghuang studiesontheregulationofproteinexpressionandmolecularmechanismsofpolyunsaturatedfattyacidsinhumanaorticendothelialcellsandhepaticcells
AT huángchúnyíng studiesontheregulationofproteinexpressionandmolecularmechanismsofpolyunsaturatedfattyacidsinhumanaorticendothelialcellsandhepaticcells
AT chunyinghuang duōyuánbùbǎohézhīfángsuānzàirénlèizhǔdòngmàinèipíxìbāoyǔgānzàngxìbāozhōngdiàokòngdànbáizhìbiǎoxiànyǔfēnzijīzhuǎnzhīyánjiū
AT huángchúnyíng duōyuánbùbǎohézhīfángsuānzàirénlèizhǔdòngmàinèipíxìbāoyǔgānzàngxìbāozhōngdiàokòngdànbáizhìbiǎoxiànyǔfēnzijīzhuǎnzhīyánjiū
_version_ 1718378161292443648